Cited by 175Menopause: Health Impacts and TreatmentsEstrogen and related hormone effectsHormonal and reproductive studies

The DOI matches its Crossref record; 339 of the 343 references it cites were found in a registry or an index.

Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment

Flores, Valerie A, Pal, Lubna, Manson, JoAnn E·2021·Endocrine Reviews

DOI 10.1210/endrev/bnab011

Open this paper in CoChat — free account

Abstract

Hormone therapy (HT) is an effective treatment for menopausal symptoms, including vasomotor symptoms and genitourinary syndrome of menopause. Randomized trials also demonstrate positive effects on bone health, and age-stratified analyses indicate more favorable effects on coronary heart disease and all-cause mortality in younger women (close proximity to menopause) than in women more than a decade past menopause. In the absence of contraindications or other major comorbidities, recently menopausal women with moderate or severe symptoms are appropriate candidates for HT. The Women’s Health Initiative (WHI) hormone therapy trials—estrogen and progestin trial and the estrogen-alone trial—clarified the benefits and risks of HT, including how the results differed by age. A key lesson from the WHI trials, which was unfortunately lost in the posttrial cacophony, was that the risk:benefit ratio and safety profile of HT differed markedly by clinical characteristics of the participants, especially age, time since menopause, and comorbidity status. In the present review of the WHI and other recent HT trials, we aim to provide readers with an improved understanding of the importance of the timing of HT initiation, type and route of administration, and of patient-specific considerations that should be weighed when prescribing HT.

Integrity signals

Registry

Crossref · 10.1210/endrev/bnab011

Cites

339 of 339 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women's Health Initiative Randomized Controlled Trial
(2004) · JAMA · doi:10.1001/jama.291.14.1701 · Cited by 4,534
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.002 · Cited by 3,845
The Protective Effects of Estrogen on the Cardiovascular System
Mendelsohn, M. E., & Karas, R. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402306 · Cited by 3,119
Breast cancer and hormone-replacement therapy in the Million Women Study
Beral, V. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,986
Design of the Women’s Health Initiative Clinical Trial and Observational Study
The Women’s Health Initiative Study Group (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,580
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
Calle, E. E., Heath Jr., C. W., Coates, R. J., Liff, J. M., Franceschi, S., Talamini, R., Chantarakul, N., Koetsawang, S., Rachawat, D., Morabia, A., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)08233-0 · Cited by 2,450
Untitled work
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Postmenopausal Estrogen Therapy and Cardiovascular Disease
Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., ROSNER, B. A., Speizer, F. E., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109123251102 · Cited by 2,000
Self-citation
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
Grady, D. G., Herrington, D. M., Bittner, V., Blumenthal, R. S., Davidson, M., Hlatky, M. A., Hsia, J. A., Hulley, S. B., Herd, A. J., Khan, S. S., et al. (2002) · JAMA · doi:10.1001/jama.288.1.49 · Cited by 1,921
Calcium plus Vitamin D Supplementation and the Risk of Fractures
Jackson, R. D., LaCroix, A. Z., Gass, M. L. S., Wallace, R. B., Robbins, J. A., Lewis, C. E., Bassford, T. L., Beresford, S. A. A., Black, H. R., Blanchette, P. L., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055218 · Cited by 1,876
Self-citation
Estrogen receptors: how do they signal and what are their targets
Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Ström, A., Treuter, E., Warner, M., et al. (2007) · Physiological Reviews · doi:10.1152/physrev.00026.2006 · Cited by 1,857
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007) · JAMA · doi:10.1001/jama.297.13.1465 · Cited by 1,741
Self-citation
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
Self-citation
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
Delmas, P. D., Bjarnason, N. H., Mitlak, B., Ravoux, A.-C., Shah, A. S., Huster, W. J., Draper, M. W., & Christiansen, C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712043372301 · Cited by 1,630
Harrison's Principles of Internal Medicine.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-813_1 · Cited by 1,537
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487
Self-citation
Menopause and Risk of Cardiovascular Disease
Kannel, W. B., Hjortland, M. C., McNAMARA, P. M., & Gordon, T. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-4-447 · Cited by 1,408
Evolutionary and biomedical insights from the rhesus macaque genome.
Gibbs, R. A., Rogers, J., Katze, M. G., Bumgarner, R., Weinstock, G. M., Mardis, E. R., Remington, K. A., Strausberg, R. L., Venter, J. C., Wilson, R. K., et al. (2007) · Science · doi:10.1126/science.1139247 · Cited by 1,403
Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.
Bush, T. L., Barrett-Connor, E. L., Cowan, L. D., Criqui, M. H., Wallace, R. B., Suchindran, C., Tyroler, H. A., & Rifkind, B. M. (1987) · Circulation · doi:10.1161/01.cir.75.6.1102 · Cited by 1,346
Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease
Grodstein, F., Stampfer, M. J., Manson, J. E., Colditz, G. A., Willett, W. C., ROSNER, B. A., Speizer, F. E., & Hennekens, C. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608153350701 · Cited by 1,294
Self-citation
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T. D., Rogers, W. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430801 · Cited by 1,242
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density The Women's Health Initiative Randomized Trial
Cauley, J. A. (2003) · JAMA · doi:10.1001/jama.290.13.1729 · Cited by 1,229
Postmenopausal Hormone Therapy and Mortality
Grodstein, F., Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Joffe, M. M., ROSNER, B. A., Fuchs, C. S., Hankinson, S. E., Hunter, D. J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706193362501 · Cited by 1,167
Self-citation
A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease
Grodstein, F., Manson, J. E., Colditz, G. A., Willett, W. C., Speizer, F. E., & Stampfer, M. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00008 · Cited by 1,063
Self-citation
Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Barrett-Connor, E., Mosca, L., Collins, P., Geiger, M. J., Grady, D., Kornitzer, M., McNabb, M. A., & Wenger, N. K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062462 · Cited by 1,048
The 2017 hormone therapy position statement of The North American Menopause Society
The North American Menopause Society (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000921 · Cited by 1,042
CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment
Jin, Y., Desta, Z., Stearns, V., Ward, B. A., Ho, H., Lee, K.-H., Skaar, T. C., Storniolo, A. M., Li, L., Araba, A., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji005 · Cited by 951
Estrogen Therapy in Postmenopausal Women
Yaffe, K. S., Sawaya, G. F., Lieberburg, I. M., & Grady, D. G. (1998) · JAMA · doi:10.1001/jama.279.9.688 · Cited by 947
Menopause and Coronary Heart Disease
Gordon, T., Kannel, W. B., Hjortland, M. C., & McNAMARA, P. M. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-2-157 · Cited by 904
Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women
Canonico, M., Oger, E., Plu‐Bureau, G., Conard, J., Meyer, G., Levesque, H., Trillot, N., Barrellier, M. ‐., Wahl, D. G., Emmerich, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.642280 · Cited by 867
Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine
Stearns, V. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg108 · Cited by 848
2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Goff, D. C., Lloyd‐Jones, D. M., Bennett, G. C., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D. A., O’Donnell, C. J., et al. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · Cited by 840
Prevention and treatment of postmenopausal osteoporosis
Tella, S. H., & Gallagher, J. C. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.09.008 · Cited by 786
Vascular effects of early versus late postmenopausal treatment with estradiol
Hodis, H. N., Mack, W. J., Henderson, V. W., Shoupe, D., Budoff, M. J., Hwang-Levine, J., Li, Y., Feng, M., Dustin, L., Kono, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505241 · Cited by 779
The Menopause Transition: Signs, Symptoms, and Management Options
Santoro, N. F., Roeca, C. M., Peters, B. A., & Neal-Perry, G. S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa764 · Cited by 774
Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence
† (2019) · The Lancet · doi:10.1016/s0140-6736(19)31709-x · Cited by 769
Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.
Soares, C. N., Almeida, O., Joffe, H., & Cohen, L. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.529 · Cited by 715
Unequal risks for breast cancer associated with different hormone replacement therapies: Results from the E3N cohort study
Fournier, A., Berrino, F., & Clavel-Chapelon, F. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9523-x · Cited by 693
Effects of Raloxifene on Serum Lipids and Coagulation Factors in Healthy Postmenopausal Women
Walsh, B. W. (1998) · JAMA · doi:10.1001/jama.279.18.1445 · Cited by 691
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
Santen, R. J., Allred, D. C., Ardoin, S. P., Archer, D. F., Boyd, N. F., Braunstein, G. D., Burger, H., Colditz, G. A., Davis, S. R., Gambacciani, M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2509 · Cited by 687
Self-citation
Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene
Martino, S., Cauley, J. A., Barrett-Connor, E., Powles, T. J., Mershon, J., Disch, D., Secrest, R. J., Cummings, S. R., & For the CORE Investigators (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh319 · Cited by 684
Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers
Rebbeck, T. R., Levin, A. M., Eisen, A. F., Snyder, C., Watson, P. A., Cannon‐Albright, L., Isaacs, C. J., Olopade, O., Garber, J. E., Godwin, A. K., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.17.1475 · Cited by 670
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality
Manson, J. E., Aragaki, A. K., Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Chlebowski, R. T., Howard, B. V., Thomson, C. A., Margolis, K. L., et al. (2017) · JAMA · doi:10.1001/jama.2017.11217 · Cited by 663
Self-citation
Local oestrogen for vaginal atrophy in postmenopausal women
Lethaby, A. E., Ayeleke, R. O., & Roberts, H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001500.pub3 · Cited by 606
Postmenopausal Estrogen Use, Cigarette Smoking, and Cardiovascular Morbidity in Women over 50
Wilson, P. W. F., Garrison, R. J., & Castelli, W. P. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510243131702 · Cited by 604
Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens
Jick, H., Derby, L. E., Myers, M. W., Vasilakis‐Scaramozza, C., & Newton, K. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07114-0 · Cited by 598
BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPY
Christiansen, C., Christensen, M. S., & Transbøl, I. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91848-1 · Cited by 595
Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women
Waters, D. D., Alderman, E. L., Hsia, J. A., Howard, B. V., Cobb, F. R., Rogers, W. J., Ouyang, P., Thompson, P. D., Tardif, J., Higginson, L., et al. (2002) · JAMA · doi:10.1001/jama.288.19.2432 · Cited by 580
Treatment of Postmenopausal Osteoporosis with Calcitriol or Calcium
Tilyard, M., Spears, G. F. S., Thomson, J., & Dovey, S. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202063260601 · Cited by 574
Estrogen replacement in perimenopause-related depression: A preliminary report
Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Tobin, M., Roca, C. A., Murphy, J. H., & Rubinow, D. R. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106004 · Cited by 572
Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis
Canonico, M., Plu-Bureau, G., Lowe, G. D. O., & Scarabin, P.-Y. (2008) · BMJ · doi:10.1136/bmj.39555.441944.be · Cited by 569
Long-term health consequences of premature or early menopause and considerations for management
Faubion, S. S., Kuhle, C. L., Shuster, L. T., & Rocca, W. A. (2015) · Climacteric · doi:10.3109/13697137.2015.1020484 · Cited by 566
Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
MacLennan, A. H., Broadbent, J. L., Lester, S., & Moore, V. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002978.pub2 · Cited by 543
The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society
(2020) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001609 · Cited by 539
Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy
LaCroix, A. Z. (2011) · JAMA · doi:10.1001/jama.2011.382 · Cited by 538
Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D
Ström, A., Hartman, J., Foster, J. S., Kietz, S., Wimalasena, J., & Gustafsson, J.-Α. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308319100 · Cited by 535
HABITS (hormonal replacement therapy after breast cancer—is it safe?), a randomised comparison: trial stopped
Holmberg, L., & Anderson, H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15493-7 · Cited by 533
Hormone Replacement Therapy and Prevention of Nonvertebral Fractures
Torgerson, D. J., & Bell-Syer, S. E. (2001) · JAMA · doi:10.1001/jama.285.22.2891 · Cited by 528
Hormone-replacement therapy: current thinking
Lobo, R. A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.164 · Cited by 526
Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause
Sullivan, S. D., Sarrel, P. M., & Nelson, L. M. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.046 · Cited by 519
Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS–Cognitive and Affective Study
Gleason, C. E., Dowling, N. M., Wharton, W., Manson, J. E., Miller, V. M., Atwood, C., Brinton, E. A., Cedars, M. I., Løbo, R. A., Merriam, G. R., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001833 · Cited by 512
Self-citation
Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women
Chlebowski, R. T., Kuller, L. H., Prentice, R. L., Stefanick, M. L., Manson, J. E., Gass, M. L. S., Aragaki, A. K., Ockene, J. K., Lane, D. S., Sarto, G. E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807684 · Cited by 468
Self-citation
Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials
Chlebowski, R. T., Anderson, G. L., Aragaki, A. K., Manson, J. E., Stefanick, M. L., Pan, K., Barrington, W. E., Kuller, L. H., Simon, M. S., Lane, D. S., et al. (2020) · JAMA · doi:10.1001/jama.2020.9482 · Cited by 441
Self-citation
Progestogens Used in Postmenopausal Hormone Therapy: Differences in Their Pharmacological Properties, Intracellular Actions, and Clinical Effects
Stanczyk, F. Z., Hapgood, J. P., Winer, S., & Mishell, D. R. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1008 · Cited by 429
The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women
Grodstein, F., & Stampfer, M. J. (1995) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(95)80012-3 · Cited by 417
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
Rebbeck, T. R., Friebel, T. M., Wagner, T. M., Lynch, H. T., Garber, J. E., Daly, M. B., Isaacs, C. J., Olopade, O. I., Neuhausen, S. L., Veer, L. V. ‘., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.8151 · Cited by 412
Hormone Therapy and the Progression of Coronary-Artery Atherosclerosis in Postmenopausal Women
Hodis, H. N., Mack, W. J., Azen, S. P., Lobo, R. A., Shoupe, D., Mahrer, P. R., Faxon, D. P., Cashin-Hemphill, L., Sanmarco, M. E., French, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030830 · Cited by 386
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study
Renoux, C., Dell’Aniello, S., Garbe, E., & Suissa, S. (2010) · BMJ · doi:10.1136/bmj.c2519 · Cited by 383
ERβ Inhibits Proliferation and Invasion of Breast Cancer Cells
Lazennec, G., Bresson, D., Lucas, A., Chauveau, C., & Vignon, F. (2001) · Endocrinology · doi:10.1210/endo.142.9.8395 · Cited by 379
Effects of long-term estrogen replacement therapy
Hammond, C. B., Jelovsek, F. R., Lee, K. L., Creasman, W. T., & Parker, R. T. (1979) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(79)90288-6 · Cited by 370
Brief report: Coronary heart disease events associated with hormone therapy in younger and older women
Salpeter, S. R., Walsh, J. M. E., Greyber, E., & Salpeter, E. E. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00389.x · Cited by 369
Effect of Lower Doses of Conjugated Equine Estrogens With and Without Medroxyprogesterone Acetate on Bone in Early Postmenopausal Women
Lindsay, R. S. (2002) · JAMA · doi:10.1001/jama.287.20.2668 · Cited by 364
Estrogen anti-inflammatory activity in brain: A therapeutic opportunity for menopause and neurodegenerative diseases
Vegeto, E., Benedusi, V., & Maggi, A. C. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.04.001 · Cited by 364
Androgen therapy in women: a reappraisal: an Endocrine Society Clinical Practice Guideline
Wierman, M. E., Arlt, W., Basson, R., Davis, S. R., Miller, K. K., Murad, M. H., Rosner, W., & Santoro, N. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2260 · Cited by 363
Levonorgestrel‐releasing intrauterine device in the treatment of menorrhagia
Andersson, J. K., & Rybo, G. (1990) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1990.tb16240.x · Cited by 358
MENOPAUSAL OESTROGEN THERAPY AND PROTECTION FROM DEATH FROM ISCHAEMIC HEART DISEASE
Ross, R., Mack, T. M., Paganini‐Hill, A., Arthur, M., & Henderson, B. E. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92138-3 · Cited by 356
Annual injection of vitamin D and fractures of aged bones
Heikinheimo, R., Inkovaara, J. A., Harju, E., Haavisto, M., Kaarela, R. H., Kataja, J. M., Kokko, A. M.-L., Kolho, L. A., & Rajala, S. (1992) · Calcified Tissue International · doi:10.1007/bf00298497 · Cited by 354
A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women
Draper, M. W., Flowers, D. E., Huster, W. J., Neild, J. A., Harper, K. D., & Arnaud, C. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110615 · Cited by 351
Arterial Imaging Outcomes and Cardiovascular Risk Factors in Recently Menopausal Women
Harman, S. M., Black, D. M., Naftolin, F. N., Brinton, E. A., Budoff, M. J., Cedars, M. I., Hopkins, P. N., Løbo, R. A., Manson, J. E., Merriam, G. R., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0353 · Cited by 347
Self-citation
Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate
Utian, W. H., Shoupe, D., Bachmann, G. A., Pinkerton, J., & Pickar, J. H. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01791-5 · Cited by 347
Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis
Barrionuevo, P., Kapoor, E., Asi, N., Alahdab, F., Mohammed, K. S., Benkhadra, K., Almasri, J., Farah, W. H., Sarigianni, M., Muthusamy, K., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00192 · Cited by 344
Postmenopausal Estrogen Use and Coronary Atherosclerosis
Sullivan, J. M., ZWAAG, R. V., LEMP, G. F., HUGHES, J. P., MADDOCK, V., KROETZ, F. W., RAMANATHAN, K. B., & MIRVIS, D. M. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-358 · Cited by 333
Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial
Cherry, N., Gilmour, K., Hannaford, P. C., Heagerty, A. M., Khan, M. A., Kitchener, H. C., McNamee, R., Elstein, M., Kay, C. R., Seif, M. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)12001-0 · Cited by 333
Postmenopausal use of estrogen and occlusion of coronary arteries
Gruchow, H. W., Anderson, A. J., Barboriak, J. J., & Sobocinski, K. A. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90063-4 · Cited by 327
Reduced Mortality Associated With Long-Term Postmenopausal Estrogen Therapy
Ettinger, B. B., FRIEDMAN, G. D., Bush, T., & QuesenberryJr, C. (1996) · Obstetrics and Gynecology · doi:10.1016/0029-7844(95)00358-4 · Cited by 326
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial
Chlebowski, R. T., Schwartz, A. G., Wakelee, H. A., Anderson, G. L., Stefanick, M. L., Manson, J. E., Rodabough, R. J., Chien, J. W., Wactawski‐Wende, J., Gass, M. L. S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61526-9 · Cited by 322
Self-citation
Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women
Bygdeman, M., & Swahn, M. L. (1996) · Maturitas · doi:10.1016/0378-5122(95)00955-8 · Cited by 302
The Risk of Myocardial Infarction Associated With the Combined Use of Estrogens and Progestins in Postmenopausal Women
Psaty, B. M. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.12.1333 · Cited by 301
Commonly Used Types of Postmenopausal Estrogen for Treatment of Hot Flashes: Scientific Review
Nelson, H. D. (2004) · JAMA · doi:10.1001/jama.291.13.1610 · Cited by 296
Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
Edwards, D., & Panay, N. (2015) · Climacteric · doi:10.3109/13697137.2015.1124259 · Cited by 272
Postmenopausal Hormone Therapy and Risk of Idiopathic Venous Thromboembolism
Canonico, M., Fournier, A., Carcaillon‐Bentata, L., Olié, V., Plu‐Bureau, G., Oger, E., Mesrine, S., Boutron‐Ruault, M., Clavel‐Chapelon, F., & Scarabin, P. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.196022 · Cited by 270
A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT Atherosclerosis Study
Clarke, S., Kelleher, J., Lloyd‐Jones, H., Slack, M. C., & Schofield, P. M. (2002) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2002.01544.x · Cited by 267
Risk of cancer in women receiving hormone replacement therapy
Adami, H., Persson, I. R., Hoover, R. N., Schairer, C., & Bergkvist, L. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440515 · Cited by 267
Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression
Schmidt, P. J., Dor, R. R. B., Martinez, P. E., Guerrieri, G. M., Harsh, V., Thompson, K., Koziol, D. E., Nieman, L. K., & Rubinow, D. R. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0111 · Cited by 265
Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions
Suzuki, S., Brown, C. M., Cruz, C. D. D., Yang, E., Bridwell, D. A., & Wise, P. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610394104 · Cited by 257
Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile
Løbo, R. A., Pinkerton, J. V., Gass, M. L. S., Dorin, M. H., Ronkin, S., Pickar, J. H., & Constantine, G. D. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.113 · Cited by 255
The impact of hormones on menopausal sexuality: a literature review
Bachmann, G. A., & Leiblum, S. R. (2004) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000075502.60230.28 · Cited by 253
Cognitive effects of estradiol after menopause
Henderson, V. W., John, J. A. S., Hodis, H. N., McCleary, C. A., Stanczyk, F. Z., Shoupe, D., Kono, N., Dustin, L., Allayee, H., & Mack, W. J. (2016) · Neurology · doi:10.1212/wnl.0000000000002980 · Cited by 251
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause
Labrie, F., Archer, D. F., Koltun, W. D., Vachon, A., Young, D. G., Frenette, L., Portman, D. J., Montesino, M., Côté, I., Parent, J., et al. (2016) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000571 · Cited by 247
Prophylactic oophorectomy in premenopausal women and long-term health
Shuster, L. T., Gostout, B. S., Grossardt, B. R., & Rocca, W. A. (2008) · Menopause international · doi:10.1258/mi.2008.008016 · Cited by 245
Hormone Replacement Therapy After a Diagnosis of Breast Cancer in Relation to Recurrence and Mortality
O’Meara, E. S., Rossing, M. A., Daling, J. R., Elmore, J. G., Barlow, W. E., & Weiss, N. S. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.10.754 · Cited by 243
Inhibition of Postmenopausal Atherosclerosis Progression: A Comparison of the Effects of Conjugated Equine Estrogens and Soy Phytoestrogens
Clarkson, T. B., Anthony, M. S., & Morgan, T. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7151 · Cited by 242
Semi-security and psychiatric hospitals.
Ln, W. (1974) · PubMed · Cited by 239
Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin
Anderson, G. L., Chlebowski, R. T., Rossouw, J. E., Rodabough, R. J., McTiernan, A., Margolis, K. L., Aggerwal, A., Curb, J. D., Hendrix, S. L., Hubbell, F. A., et al. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.05.004 · Cited by 238
Randomized Double-Blind Trial of Estrogen Replacement Therapy Versus Placebo in Stage I or II Endometrial Cancer: A Gynecologic Oncology Group Study
Barakat, R. R., Bundy, B. N., Spirtos, N. M., Bell, J., & Mannel, R. S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8464 · Cited by 237
Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women
Lindsay, R., Gallagher, J. C., Kagan, R., Pickar, J. H., & Constantine, G. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.02.093 · Cited by 234
Estrogen replacement therapy and protection from acute myocardial infarction
Henderson, B. E., Paganini‐Hill, A., & Ross, R. K. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(88)80074-7 · Cited by 234
The women's health initiative postmenopausal hormone trials: overview and baseline characteristics of participants
Stefanick, M. L., Cochrane, B. B., Hsia, J. A., Barad, D. H., LIU, J. H., & Johnson, S. R. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00045-0 · Cited by 231
Low-Dose Esterified Estrogen Therapy
Genant, H. K. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440430091011 · Cited by 228
Long-Term Effects on Cognitive Function of Postmenopausal Hormone Therapy Prescribed to Women Aged 50 to 55 Years
Espeland, M. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.7727 · Cited by 227
Hormone Replacement Therapy and the Cardiovascular System
Ouyang, P., Michos, E. D., & Karas, R. H. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.076 · Cited by 216
Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial
Prague, J., Roberts, R. E., Comninos, A. N., Clarke, S. A., Jayasena, C. N., Nash, Z., Doyle, C., Papadopoulou, D., Bloom, S. R., Mohideen, P., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30823-1 · Cited by 209
Cardiovascular Effects of Estrogen and Lipid-Lowering Therapies in Postmenopausal Women
Guetta, V., & Cannon, R. O. (1996) · Circulation · doi:10.1161/01.cir.93.10.1928 · Cited by 207
Cognitive Function in Postmenopausal Women Treated with Raloxifene
Yaffe, K. S., Krueger, K., Sarkar, S., Grady, D., Barrett-Connor, E. L., Cox, D. A., & Nickélsen, T. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441604 · Cited by 204
Bayesian Meta-analysis of Hormone Therapy and Mortality in Younger Postmenopausal Women
Salpeter, S. R., Cheng, J., Thabane, L., Buckley, N. S., & Salpeter, E. E. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.05.021 · Cited by 201
Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women.
Folsom, A. R., Mink, P. J., Sellers, T. A., Hong, C. P., Zheng, W., & Potter, J. D. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.8_pt_1.1128 · Cited by 200
Coagulation Activation Following Estrogen Administration to Postmenopausal Women
Caine, Y. G., Bauer, K. A., Barzegar, S., Cate, H. T., Sacks, F. M., Walsh, B. W., Schiff, I., & ROSENBERG, R. D. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646283 · Cited by 200
A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena
Gemzell‐Danielsson, K., Schellschmidt, I., & Apter, D. L. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.12.003 · Cited by 200
Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism
Løbo, R. A., Bush, T. L., Carr, B. R., & Pickar, J. H. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01829-5 · Cited by 199
Cognitive Function in Postmenopausal Women Treated With Raloxifene
Yaffe, K. S., Krueger, K. A., Sarkar, S., Grady, D. G., Barrett-Connor, E. L., Cox, D. A., & Nickélsen, T. (2001) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200109000-00018 · Cited by 197
Oral Medroxyprogesterone in the Treatment of Postmenopausal Symptoms
Schiff, I. (1980) · JAMA · doi:10.1001/jama.1980.03310130021021 · Cited by 195
Use of Menopausal Estrogens and Medroxyprogesterone in the United States, 1982-1992
Wysowski, D. K. (1995) · Obstetrics and Gynecology · doi:10.1016/0029-7844(94)00339-f · Cited by 195
Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers
Eisen, A. F., Lubiński, J., Gronwald, J., Møller, P., Lynch, H. T., Klijn, J. G. M., Kim‐Sing, C., Neuhausen, S. L., Gilbert, L., Ghadirian, P., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn313 · Cited by 194
Postmenopausal Hormone Therapy and Stroke
Grodstein, F., Manson, J. E., Stampfer, M. J., & Rexrode, K. M. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.8.861 · Cited by 191
Self-citation
Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy
Labrie, F., Archer, D. F., Bouchard, C., Fortier, M. P., Cusan, L., Gomez, J., Girard, G., Baron, M., Ayotte, N. J., Moreau, M., et al. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31819e8e2d · Cited by 189
The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?
Miller, V. M., Naftolin, F. N., Asthana, S., Black, D. M., Brinton, E. A., Budoff, M. J., Cedars, M. I., Dowling, N. M., Gleason, C. E., Hodis, H. N., et al. (2019) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001326 · Cited by 188
Self-citation
Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density.
Persson, I., Thurfjell, E., & Holmberg, L. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.10.3201 · Cited by 186
Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy
Pickar, J. H., Yeh, I., Bachmann, G. A., & Speroff, L. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.05.094 · Cited by 186
Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group
Genant, H. K. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.22.2609 · Cited by 186
Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens
Pinkerton, J. V., Utian, W. H., Constantine, G. D., Olivier, S., & Pickar, J. H. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181a7df0d · Cited by 185
Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels
Santen, R. J. (2014) · Climacteric · doi:10.3109/13697137.2014.947254 · Cited by 180
POSTMENOPAUSAL ESTROGEN USE AND MORTALITY
Criqui, M. H., Suarez, L., Barrett-Connor, E. L., McPhillips, J. B., Wingard, D. L., & Garland, C. F. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115008 · Cited by 179
Speroff's Clinical Gynecologic Endocrinology and Infertility
Taylor, H. S., Pal, L., & Seli, E. U. (2019) · Cited by 179
Self-citation
Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women
Hong, M. K., Romm, P. A., Reagan, K., Green, C. E., & Rackley, C. E. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91300-s · Cited by 178
Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study.
Petitti, D. B., Perlman, J. A., & Sidney, S. (1987) · PubMed · Cited by 178
Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women
Komesaroff, P. A., Black, C. V. S., Cable, V., & Sudhir, K. (2001) · Climacteric · doi:10.1080/cmt.4.2.144.150 · Cited by 172
Postmenopausal hormone therapy and body composition—a substudy of the estrogen plus progestin trial of the Women’s Health Initiative
Chen, Z., Bassford, T. L., Green, S. B., Cauley, J. A., Jackson, R. D., LaCroix, A. Z., LeBoff, M. S., Stefanick, M. L., & Margolis, K. L. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.3.651 · Cited by 172
Breast cancer risk with postmenopausal hormonal treatment
Collins, J. A., Blake, J. M., & Crosignani, P. G. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi028 · Cited by 171
Increased Incidence of Endometrial Cancer Following the Women's Health Initiative: An Assessment of Risk Factors
Constantine, G. D., Kessler, G., Graham, S., & Goldstein, S. R. (2018) · Journal of Women s Health · doi:10.1089/jwh.2018.6956 · Cited by 170
Transdermal Progesterone Cream for Vasomotor Symptoms and Postmenopausal Bone Loss
Leonetti, H. B., Longo, S., & Anasti, J. N. (1999) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(99)00266-5 · Cited by 170
Myocardial Infarction and Estrogen Therapy in Post-Menopausal Women
Rosenberg, L. A., Armstrong, B. K., & Jick, H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197606032942302 · Cited by 168
Long-acting reversible contraceptive (LARCs) methods
Bahamondes, L. G., Fernandes, A. M. D. S., MONTEIRO, I. M. U., & Bahamondes, M. V. (2019) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2019.12.002 · Cited by 167
Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes, N07C1
Loprinzi, C. L., Qin, R., Baclueva, E. P., Flynn, K., Rowland, K. M., Graham, D. L., Erwin, N. K., Dakhil, S. R., Jurgens, D. J., & Burger, K. N. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.5647 · Cited by 165
Absorption of Estrogens from Vaginal Creams
Rigg, L. A., Hermann, H. W., & Yen, S. S. C. (1978) · New England Journal of Medicine · doi:10.1056/nejm197801262980406 · Cited by 159
Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens
(2015) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000404 · Cited by 157
The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review
Oliver‐Williams, C., Glišić, M., Shahzad, S., Brown, E., Baena, C. P., Chadni, M., Chowdhury, R., Franco, O. H., & Muka, T. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy039 · Cited by 155
Breast Cancer Risk in Postmenopausal Women Using Estrogen-Only Therapy
Lyytinen, H. K., Pukkala, ., & Ylikorkala, O. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000241091.86268.6e · Cited by 153
Hormone Replacement Therapy and Incidence of Acute Myocardial Infarction
Varas‐Lorenzo, C., García‐Rodríguez, L. A., Perez‐Gutthann, S., & Oliart, A. D. (2000) · Circulation · doi:10.1161/01.cir.101.22.2572 · Cited by 150
Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial
Constantine, G. D., Graham, S. A., Portman, D. J., Rosen, R., & Kingsberg, S. A. (2014) · Climacteric · doi:10.3109/13697137.2014.954996 · Cited by 150
Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms
Simon, J. A., Portman, D. J., Kaunitz, A. M., Mekonnen, H., Kazempour, K., Bhaskar, S., & Lippman, J. S. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3182a66aa7 · Cited by 146
Effects of raloxifene hydrochloride on the endometrium of postmenopausal women
Boss, S. M., Huster, W. J., Neild, J. A., Glant, M. D., Eisenhut, C. C., & Draper, M. W. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70091-7 · Cited by 144
Vascular Effects of Synthetic or Natural Progestagen Combined With Conjugated Equine Estrogen in Healthy Postmenopausal Women
Koh, K. K., Jin, D., Yang, S. H., Lee, S.-K., Hwang, H. Y., Kang, M. H., Kim, W. S., Kim, D. S., Choi, I. S., & Shin, E. K. (2001) · Circulation · doi:10.1161/01.cir.103.15.1961 · Cited by 142
Noncontraceptive estrogens and progestins: use patterns over time.
Dl, K., Baum, C., & Forbes, M. B. (1985) · PubMed · Cited by 142
Menopausal Hormone Therapy and Risk of Endometrial Carcinoma Among Postmenopausal Women in the European Prospective Investigation into Cancer and Nutrition
Allen, N. E., Tsilidis, K. K., Key, T. J., Dossus, L., Kaaks, R., Lund, E., Bakken, K. S., Gavrilyuk, O. N., Overvad, K., Tjønneland, A. M., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq300 · Cited by 141
Spontaneous conceptions and live birth after heterotopic ovarian transplantation: is there a germline stem cell connection?
Oktay, K. (2006) · Human Reproduction · doi:10.1093/humrep/del007 · Cited by 139
Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition
Kantarci, K., Lowe, V. J., Lesnick, T. G., Tosakulwong, N., Bailey, K. R., Fields, J. A., Shuster, L. T., Zuk, S. M., Senjem, M. L., Mielke, M. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160258 · Cited by 135
Effect of hormone therapy on the risk of bone fractures
Zhu, L., Jiang, X., Sun, Y., & Shu, W. (2015) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000519 · Cited by 133
Use of Hormone Replacement Therapy and Adenocarcinomas and Squamous Cell Carcinomas of the Uterine Cervix
Lacey, J. V., Brinton, L. A., Barnes, W. A., Gravitt, P. E., Greenberg, M., Hadjimichael, O. C., McGowan, L., Mortel, R., Schwartz, P. E., Kurman, R. J., et al. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5731 · Cited by 133
SSRIs for Hot Flashes: A Systematic Review and Meta-Analysis of Randomized Trials
Shams, T. M., Firwana, B., Habib, F., Alshahrani, A., AlNouh, B., Murad, M. H., & Ferwana, M. S. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2535-9 · Cited by 132
Three-year continuation of reversible contraception
Diedrich, J. T., Zhao, Q., Madden, T. E., Secura, G. M., & Peipert, J. F. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.08.001 · Cited by 131
Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86.
Hemminki, E., Kennedy, D., Baum, C., & McKinlay, S. M. (1988) · American Journal of Public Health · doi:10.2105/ajph.78.11.1479 · Cited by 131
Risk factors and noncontraceptive estrogen use in women with and without coronary disease
McFarland, K. F., Boniface, M. E., Hornung, C. A., Earnhardt, W., & Humphries, J. O. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90398-0 · Cited by 131
Use of postmenopausal hormones and risk of myocardial infarction.
Bain, C., Willett, W. C., Hennekens, C. H., ROSNER, B. A., Belanger, C. F., & Speizer, F. E. (1981) · Circulation · doi:10.1161/01.cir.64.1.42 · Cited by 126
Hormone replacement therapy in previously treated breast cancer patients
Wile, A. G., Opfell, R. W., & Margileth, D. A. (1993) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)80848-7 · Cited by 124
Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally
Bachmann, G. A., Bouchard, C., Hoppe, D., Ranganath, R., Altomare, C. J., Vieweg, A. J., Graepel, J., & Helzner, E. C. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181a48c4e · Cited by 124
Hormonal replacement therapy in patients after cervical cancer treatment
Ploch, E. (1987) · Gynecologic Oncology · doi:10.1016/0090-8258(87)90270-8 · Cited by 123
Lower Risk of Cardiovascular Events in Postmenopausal Women Taking Oral Estradiol Compared With Oral Conjugated Equine Estrogens
Smith, N. L., Blondon, M., Wiggins, K. L., Harrington, L. B., Vlieg, A. V. H., Floyd, J. S., Hwang, M., Bis, J. C., McKnight, B., Rice, K. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.11074 · Cited by 122
Gabapentin for the treatment of menopausal hot flashes
Butt, D. A., Lock, M. I., Lewis, J. E., Ross, S., & Moineddin, R. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3180dca175 · Cited by 120
Hormone Therapy and In-Hospital Survival After Myocardial Infarction in Postmenopausal Women
Shlipak, M. G., Angeja, B. G., Go, A. S., Frederick, P. D., Canto, J. G., & Grady, D. G. (2001) · Circulation · doi:10.1161/hc4401.98414 · Cited by 120
Hormone therapy and risk of myocardial infarction: a national register study
Løkkegaard, E., Andreasen, A. H., Jacobsen, R. K., Nielsen, L. H., Agger, C., & Lidegaard, Ø. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn408 · Cited by 120
Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis
Rovinski, D., Ramos, R. B., Fighera, T. M., Casanova, G. K., & Spritzer, P. M. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.06.014 · Cited by 120
A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause
Biehl, C., Plotsker, O., & Mirkin, S. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001221 · Cited by 119
Effects of a New Hormone Therapy, Drospirenone and 17-β-Estradiol, in Postmenopausal Women With Hypertension
White, W. B., Hanes, V., Chauhan, V., & Pitt, B. (2006) · Hypertension · doi:10.1161/01.hyp.0000232179.60442.84 · Cited by 119
Breast Effects of Bazedoxifene-Conjugated Estrogens
Pinkerton, J. V., Harvey, J. A., Pan, K., Thompson, J. R., Ryan, K. A., Chines, A. A., & Mirkin, S. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31828c5974 · Cited by 117
Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: A meta-analysis
Shim, S., Lee, S. J., & Kim, S. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.03.006 · Cited by 117
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause
Labrie, F., Archer, D. F., Koltun, W. D., Vachon, A., Young, D. G., Frenette, L., Portman, D. J., Montesino, M., Côté, I., Parent, J., et al. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001238 · Cited by 117
Intrauterine 10μg and 20μg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response
Raudaskoski, T., Tapanainen, J. S., Tomás, E. I., Luotola, H., Pekonen, F., Ronni-Sivula, H., Timonen, H., Riphagen, F. E., & Laatikainen, T. K. (2002) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1016/s1470-0328(02)01167-9 · Cited by 116
Effects of Ultra–Low-Dose Transdermal Estradiol on Cognition and Health-Related Quality of Life
Yaffe, K. S., Vittinghoff, E., Ensrud, K. E., Johnson, K., Diem, S. J., Hanes, V., & Grady, D. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.945 · Cited by 115
Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort
Fournier, A., Mesrine, S., Dossus, L., Boutron‐Ruault, M., Clavel‐Chapelon, F., & Chabbert‐Buffet, N. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2934-6 · Cited by 115
Loss of bone mineral density in premenopausal women with systemic lupus erythematosus.
Formiga, F., Moga, I., Solé, J. M. N., Pac, M., Mitjavila, F., & Roig-Escofet, D. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.4.274 · Cited by 115
CORONARY RISK AND ESTROGEN USE IN POSTMENOPAUSAL WOMEN1
PFEFFER, R. I., Whipple, G. H., Kurosaki, T., & CHAPMAN, J. M. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112567 · Cited by 114
Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy
Matorras, R., Elorriaga, M. A., Pijoan, J. I., Ramón, O., & Rodrı́guez-Escudero, F. J. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02981-8 · Cited by 113
Hormone replacement after breast cancer
Powles, T. J., Hickish, T., Casey, S., & O'Brien, M. E. R. (1993) · The Lancet · doi:10.1016/0140-6736(93)91931-b · Cited by 113
Estrogen Replacement Therapy After Localized Breast Cancer: Clinical Outcome of 319 Women Followed Prospectively
Vassilopoulou‐Sellin, R., Asmar, L., Hortobágyi, G. N., Klein, M. J., McNeese, M. D., Singletary, S. E., & Theriault, R. L. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1482 · Cited by 111
Hormone replacement therapy in breast cancer survivors: A cohort study
DiSaia, P. J., Grosen, E. A., Kurosaki, T., Gildea, M., Cowan, B., & Anton‐Culver, H. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70594-x · Cited by 111
Oral micronized progesterone for vasomotor symptoms—a placebo-controlled randomized trial in healthy postmenopausal women
Hitchcock, C. L., & Prior, J. C. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318247f07a · Cited by 109
Duration of Estrogen Replacement Therapy in Relation to the Risk of Incident Myocardial Infarction in Postmenopausal Women
Heckbert, S. R. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440330066007 · Cited by 109
Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literature
Igboeli, P., Andaloussi, A. E., Sheikh, U., Takala, H., Elsharoud, A., McHugh, A., Gavrilova-Jordan, L. P., Levy, S., & Al-Hendy, A. A. (2020) · Journal of Medical Case Reports · doi:10.1186/s13256-020-02426-5 · Cited by 109
The impact of micronized progesterone on the endometrium: a systematic review
Stute, P., Neulen, J., & Wildt, L. (2016) · Climacteric · doi:10.1080/13697137.2016.1187123 · Cited by 109
Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women
Labrie, F., Cusan, L., Gomez, J., Côté, I., Bérubé, R., Bélanger, P., Martel, C., & Labrie, C. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31817b6132 · Cited by 108
Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial
Collins, P. D., Mosca, L. J., Geiger, M. J., Grady, D. G., Kornitzer, M., Amewou-Atisso, M. G., Effron, M. B., Dowsett, S. A., Barrett-Connor, E. L., & Wenger, N. K. (2009) · Circulation · doi:10.1161/circulationaha.108.817577 · Cited by 107
Estradiol absorption from vaginal tablets in postmenopausal women
Notelovitz, M. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01385-0 · Cited by 104
Sex steroids to maintain cognitive function in women after the menopause: A meta-analyses of treatment trials
Hogervorst, E., & Bandelow, S. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.02.005 · Cited by 104
Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women’s Health Initiative Randomized Trial
Chlebowski, R. T., Anderson, G. L., Sarto, G. E., Haque, R., Runowicz, C. D., Aragaki, A. K., Thomson, C. A., Howard, B. V., Wactawski‐Wende, J., Chen, C., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv350 · Cited by 104
Self-citation
Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone
Vereide, A. B., Arnes, M., Straume, B., Maltau, J. M., & Ørbo, A. (2003) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.07.002 · Cited by 103
Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate
Pickar, J. H., Yeh, I., Wheeler, J. E., Cunnane, M. F., & Speroff, L. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01828-3 · Cited by 102

Research works printed but not linked: 4

Taylor, 2019, Reproductive aging, menopause transition, and menopause hormone therapy
Pinkerton, 2013, Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial, Obstet Gynecol, 121, 959, 10.1097/AOG.0b013e31828c5974 · DOI
NICE Guidelines (NG23), Menopause: diagnosis and management
Manson, 2018, Chapter 388: Menopause and postmenopausal hormone therapy

Sorted by citations

Estrogens and breast cancer
Kim, J., & Münster, P. N. (2024) · Annals of Oncology · doi:10.1016/j.annonc.2024.10.824 · Cited by 134
Hormone therapy regimens for managing the menopause and premature ovarian insufficiency
Armeni, E., Paschou, S. Α., Goulis, D. G., & Lambrinoudaki, I. V. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101561 · Cited by 116
Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society
Lambrinoudaki, I. V., Armeni, E., Goulis, D. G., Bretz, S., Ceauşu, I., Durmuşoğlu, F., Erkkola, R., Fistonić, I., Gambacciani, M., Geukes, M., et al. (2022) · Maturitas · doi:10.1016/j.maturitas.2022.04.008 · Cited by 110
Osteoporosis
Ye, C., Ebeling, P. R., & Kline, G. A. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01385-6 · Cited by 99
Gut microbiota has the potential to improve health of menopausal women by regulating estrogen
Wang, H., Shi, F., Zheng, L., Zhou, W., Mi, B., Wu, S., & Feng, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1562332 · Cited by 47

See all 175

Authors: Flores, V. A., Pal, L., & Manson, J. E.
Affiliations: Yale University (US)
Brigham and Women's Hospital (US)
Corresponding author: Flores, Valerie A
ORCID: Flores, Valerie A
Pal, Lubna
Manson, JoAnn E
Venue: Endocrine Reviews
Publisher: The Endocrine Society
Published: 2021-04-15
Volume: 42
Issue: 6
Pages: 720-752
ISSN: 0163-769X (ISSN-L)
1945-7189
DOI: 10.1210/endrev/bnab011
OpenAlex: W3155312871
Cited by: 174
References: 343
Citations by year: 2026: 40 · 2025: 45 · 2024: 44 · 2023: 30 · 2022: 13 · 2021: 2
FWCI: 3.45
Type: journal article
Language: en
Open access: closed
Licence: academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
Locations: Endocrine Reviews (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords: hormone therapy, menopause, vasomotor symptoms, genitourinary syndrome of menopause, bone health, coronary artery disease, all-cause mortality, Women's Health Initiative, estrogen-progestin, estrogen-only therapy, timing of hormone therapy initiation, route of administration, risk-benefit assessment
MeSH terms: Estrogens, Female, Humans, Menopause, Estrogen Replacement Therapy, Women's Health, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks